Paper39090255
Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing.
Al-Rabia MW and 8 others. AMB Express, 2024. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing. Papers, record 39090255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39090255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37239113 | Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239113 | PubMed |
| 2 | 35163939 | Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4H)-Oxazolone-Based Sulfonamides. | Molecules | 2022 | https://conductscience.org/library/papers/35163939 | PubMed |
| 3 | 22736963 | Quorum sensing and bacterial social interactions in biofilms. | Sensors (Basel) | 2012 | https://conductscience.org/library/papers/22736963 | PubMed |
| 4 | 30559209 | Structural determinants driving homoserine lactone ligand selection in the Pseudomonas aeruginosa LasR quorum-sensing receptor. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30559209 | PubMed |
| 5 | 15699188 | Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. | Microbiology (Reading) | 2005 | https://conductscience.org/library/papers/15699188 | PubMed |
| 6 | 36456567 | Moonlighting chaperone activity of the enzyme PqsE contributes to RhlR-controlled virulence of Pseudomonas aeruginosa. | Nat Commun | 2022 | https://conductscience.org/library/papers/36456567 | PubMed |
| 7 | 28407429 | Biofilms and host response - helpful or harmful. | APMIS | 2017 | https://conductscience.org/library/papers/28407429 | PubMed |
| 8 | 27654605 | Antimicrobial Resistance. | JAMA | 2016 | https://conductscience.org/library/papers/27654605 | PubMed |
| 9 | 38137382 | The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens. | Biomedicines | 2023 | https://conductscience.org/library/papers/38137382 | PubMed |
| 10 | 31462403 | Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. | Clin Microbiol Rev | 2019 | https://conductscience.org/library/papers/31462403 | PubMed |
| 11 | 30852658 | Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors. | Appl Microbiol Biotechnol | 2019 | https://conductscience.org/library/papers/30852658 | PubMed |
| 12 | 17026480 | Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities? | Cell Microbiol | 2006 | https://conductscience.org/library/papers/17026480 | PubMed |
| 13 | 25914685 | Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections. | Front Microbiol | 2015 | https://conductscience.org/library/papers/25914685 | PubMed |
| 14 | 38558886 | Assessing the antibacterial potential of 6-gingerol: Combined experimental and computational approaches. | Saudi Pharm J | 2024 | https://conductscience.org/library/papers/38558886 | PubMed |
| 15 | 27855208 | Swimming Motility Mediates the Formation of Neutrophil Extracellular Traps Induced by Flagellated Pseudomonas aeruginosa. | PLoS Pathog | 2016 | https://conductscience.org/library/papers/27855208 | PubMed |
| 16 | 37106705 | Diminishing the Pathogenesis of the Food-Borne Pathogen Serratia marcescens by Low Doses of Sodium Citrate. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37106705 | PubMed |
| 17 | 21504831 | A strategy for antagonizing quorum sensing. | Mol Cell | 2011 | https://conductscience.org/library/papers/21504831 | PubMed |
| 18 | 33349847 | Contribution of Swarming Motility to Dissemination in a Pseudomonas aeruginosa Murine Skin Abscess Infection Model. | J Infect Dis | 2021 | https://conductscience.org/library/papers/33349847 | PubMed |
| 19 | 23499304 | Plasmids and the spread of resistance. | Int J Med Microbiol | 2013 | https://conductscience.org/library/papers/23499304 | PubMed |
| 20 | 36361877 | RETRACTED: Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361877 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42630796 | Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa. | Can J Infect Dis Med Microbiol | 2026 | https://conductscience.org/library/papers/42630796 | PubMed |
| 42567869 | Disarming Pseudomonas aeruginosa: repurposing vardenafil, valsartan, and olmesartan as anti-virulence and antibiofilm agents. | Sci Rep | 2026 | https://conductscience.org/library/papers/42567869 | PubMed |
| 41371939 | Disclosing New Insights on Pyrazolo[3,4-d] Pyrimidine Tethered Diverse Amino Acid Candidates as Potential DHFR Inhibitors and Anti-Virulence Agents. | J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41371939 | PubMed |
| 40871342 | Anti-QS Strategies Against Pseudomonas aeruginosa Infections. | Microorganisms | 2025 | https://conductscience.org/library/papers/40871342 | PubMed |
| 39985628 | Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa. | AMB Express | 2025 | https://conductscience.org/library/papers/39985628 | PubMed |
| 39895767 | Sulforaphane Is Not Only a Food Supplement: It Diminishes the Intracellular Survival and Colonization of Salmonella enterica. | ACS Omega | 2025 | https://conductscience.org/library/papers/39895767 | PubMed |
| 39513857 | Dual Inhibition of Phosphodiesterase 3 and 4 Enzymes by Ensifentrine Protects against MRSA-Induced Lung Endothelial and Epithelial Dysfunction. | Cells | 2024 | https://conductscience.org/library/papers/39513857 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39090255
GET https://conductscience.org/api/papers/v1/39090255/references?page=2